|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA-NEW
Nominal 
0.300 -0.035 (-10.448%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -21.514% | -6.772% | -13.290% | -23.121% | -29.194% |
| ROAE (%) | N/A | N/A | N/A | -588.461% | -197.659% |
| Return on Capital Employed (%) | N/A | N/A | -251.803% | -257.947% | -340.125% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | -- | 60.498% | 64.164% | 60.841% | 71.286% |
| EBITDA Margin (%) | -548.276% | 14.236% | -23.161% | -41.581% | -122.913% |
| Pre-tax Profit Margin (%) | -453.014% | -26.218% | -65.617% | -90.330% | -159.432% |
| Net Profit Margin (%) | -1949.362% | -32.065% | -65.963% | -161.276% | -160.557% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 0.018 X | 0.063 X | 0.299 X | 0.499 X | 0.190 X |
| Quick Ratio (X) | 0.018 X | 0.054 X | 0.263 X | 0.475 X | 0.169 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 203.173% | 124.028% | 122.125% | 98.269% | 94.332% |
| Total Debt / Total Assets (%) | 104.807% | 82.176% | 87.099% | 65.746% | 57.144% |
| Net Debt / Total Assets (%) | 104.345% | 81.586% | 86.111% | 65.152% | 55.576% |
| Total Debt / Shareholders' Funds (%) | N/A | N/A | N/A | 5230.389% | 976.274% |
| Long Term Debt / Shareholders' Funds (%) | N/A | N/A | N/A | 319.743% | 64.596% |
| Net Debt / Shareholders' Funds (%) | N/A | N/A | N/A | 5183.125% | 949.484% |
| Net Cash / (Debt) ($) | (343.422M) | (820.523M) | (822.667M) | (843.761M) | (999.408M) |
| Net Cash / (Debt) per share ($) | (0.130) | (0.431) | (0.432) | (0.443) | (0.525) |
| Total Debt / Capital Employed (%) | N/A | N/A | 1401.165% | 614.179% | 594.827% |
| Interest Coverage Ratio (X) | N/A | 0.243 X | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | N/A | 94.418 Day | 133.195 Day | 129.787 Day | 137.932 Day |
| Receivables Turnover (Day) | 1083.157 Day | 40.642 Day | 30.926 Day | 73.701 Day | 152.577 Day |
| Payables Turnover (Day) | 234.158 Day | 46.801 Day | 73.521 Day | 67.026 Day | 26.218 Day |
| Remarks: | Real time quote last updated: 22/07/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -143,590,000 |
| %Change | 116.234% |
| EPS / (LPS) | RMB -0.726 |
| NBV Per Share (¥) | RMB -1.286 |